Posttranscriptional activity of eIF4E contributes to HoxA9-driven leukemogenesis

Fang Zhou; Biljana Culjkovic-Kraljacic; Christian Bach; Li Feng; Yuta Mishima; Katherine L B Borden; Daniel G Tenen

doi:10.1016/j.bneo.2025.100132

Posttranscriptional activity of eIF4E contributes to HoxA9-driven leukemogenesis

Blood Neoplasia. 2025 Jun 30;2(4):100132. doi: 10.1016/j.bneo.2025.100132. eCollection 2025 Nov.

Authors

Fang Zhou^{1

2

3}, Biljana Culjkovic-Kraljacic^{4

5}, Christian Bach^{2

3}, Li Feng^{2

3}, Yuta Mishima^{2

3

6}, Katherine L B Borden^{4

5}, Daniel G Tenen^{2

3}

Affiliations

¹ Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China.
² Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
³ Harvard Stem Cell Institute, Harvard Medical School, Boston, MA.
⁴ Department of Pathology and Cell Biology, Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada.
⁵ Department of Pharmacology and Robert H. Lurie Cancer Centre, Northwestern University, Chicago, IL.
⁶ Department of Cancer Immunotherapy and Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.

Abstract

[Figure: see text]

Abstract

Grants and funding